Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.37
-0.06 (-1.35%)
At close: Aug 15, 2025, 3:59 PM
4.33
-0.92%
After-hours: Aug 15, 2025, 04:23 PM EDT

Vanda Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
52.59M 50.04M 53.19M 47.65M 50.47M 47.46M 45.27M 38.81M 46.06M 62.5M 64.48M 65.32M 64.39M 60.19M 68.02M 70.09M 67.9M 62.67M
Cost of Revenue
4.49M 3.52M 2.59M 2.55M 4.49M 5.46M 3.46M 3.06M 3.5M 4.77M 6.24M 6.32M 6.06M 5.67M 6.24M 6.8M 6.57M 6.03M
Gross Profit
48.1M 46.52M 50.59M 45.1M 45.99M 42M 41.81M 35.75M 42.56M 57.72M 58.24M 59M 58.33M 54.53M 61.78M 63.3M 61.33M 56.64M
Operating Income
-38.5M -44.55M -10.28M -11M -10.15M -9.23M -7.09M -6M -2.87M 2M 6.63M 3.91M 3.46M -7.67M 8.64M 10.82M 12.37M 10.34M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 5.88M 5.46M 3.52M 2.98M 1.55M n/a n/a n/a n/a n/a n/a
Pretax Income
-34.89M -37.37M -6.5M -6.24M -5.52M -4.66M -1.66M -120K 2.59M 5.53M 9.61M 5.46M 3.79M -7.56M 8.61M 10.72M 12.6M 10.43M
Net Income
-27.21M -29.49M -4.91M -5.32M -4.52M -4.15M -2.4M 137K 1.52M 3.25M 6.86M 3.27M 2.57M -6.43M 7.08M 7.77M 9.65M 8.65M
Selling & General & Admin
64.62M 50.08M 39.28M 37.57M 39.47M 30.09M 23.61M 24.77M 28.4M 36.1M 32.78M 29.85M 33M 40.85M 33.45M 32.46M 28.35M 29.8M
Research & Development
21.99M 35.71M 19.84M 16.78M 16.66M 21.15M 24.34M 16.6M 16.65M 19.24M 18.45M 24.86M 21.49M 20.97M 19.33M 19.65M 20.25M 16.13M
Other Expenses
n/a 5.27M 1.75M 1.75M n/a n/a 5.43M n/a n/a 379K 379K 379K 379K 379K -26K -97K 235K 87K
Operating Expenses
86.61M 91.07M 59.12M 56.1M 56.13M 51.24M 48.91M 41.75M 45.42M 55.72M 51.62M 55.09M 54.87M 62.2M 53.15M 52.48M 48.96M 46.3M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 500K n/a n/a n/a 2.6M n/a n/a n/a 6.7M n/a n/a n/a
Cost & Expenses
91.09M 94.59M 63.46M 58.65M 60.62M 56.7M 52.37M 44.81M 48.92M 60.49M 57.85M 61.41M 60.93M 67.86M 59.38M 59.28M 55.53M 52.33M
Income Tax Expense
-7.68M -7.87M -1.58M -920K -998K -518K 739K -257K 1.07M 2.28M 2.75M 2.19M 1.22M -1.13M 1.53M 2.95M 2.95M 1.78M
Shares Outstanding (Basic)
58.99M 58.53M 58.31M 58.26M 58.22M 57.76M 57.53M 57.52M 57.45M 57.01M 56.65M 56.57M 56.51M 56.11M 55.79M 55.67M 55.58M 55.15M
Shares Outstanding (Diluted)
58.99M 58.53M 58.31M 58.26M 58.22M 57.76M 57.53M 57.6M 57.54M 57.4M 57.19M 56.97M 56.82M 56.11M 57.23M 57.04M 56.9M 56.51M
EPS (Basic)
-0.46 -0.5 -0.08 -0.09 -0.08 -0.07 -0.04 0.00 0.03 0.06 0.12 0.06 0.05 -0.11 0.13 0.14 0.17 0.16
EPS (Diluted)
-0.46 -0.5 -0.08 -0.09 -0.08 -0.07 -0.04 0.00 0.03 0.06 0.12 0.06 0.05 -0.11 0.12 0.14 0.17 0.15
EBITDA
-32.87M -31.11M -8.31M -9.03M -8.18M -7.01M -5.94M -5.42M -2.27M 2.67M 7.29M 4.59M 4.15M -6.97M 9.34M 11.53M 13.08M 11.06M
EBIT
-34.89M -32.09M -10.28M -11M -10.15M -9.23M -7.09M -6M -2.87M 5.53M 6.63M 3.91M 3.79M -7.67M 8.64M 10.72M 12.37M 10.34M
Depreciation & Amortization
2.02M 980K 1.97M 1.97M 1.97M 2.22M 1.16M 580K 602K 670K 663K 678K 690K 702K 706K 708K 712K 715K